Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Arthur Pratt

Newcastle AuthorsTitleYearFull text
Abigail Gault
Dr Christopher Stewart
Dr Arthur Pratt
Dr Neil Rajan
Cutaneous immune‐related adverse events in patients with melanoma treated with checkpoint inhibitors2021
Leonie Schittenhelm
Dr Arthur Pratt
Dr Catharien Hilkens
Dendritic cell integrin expression patterns regulate inflammation in the rheumatoid arthritis joint2021
Professor James Wason
Dr Arthur Pratt
Professor John Isaacs
Dr Elena Nikiphorou
Predictors of poor function in RA based on two prospective UK inception cohorts. Do comorbidities matter?2021
Professor John Isaacs
Dr Arthur Pratt
Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial2021
Mike Cole
Professor Fai Ng
Dr Stefan Siebert
Dr Arthur Pratt
Professor John Isaacs
et al.
TRAFIC: statistical design and analysis plan for a pragmatic early phase 1/2 Bayesian adaptive dose escalation trial in rheumatoid arthritis2021
Dr Ken Baker
Benjamin Thompson
Dr Dennis Lendrem
Adam Scadeng
Dr Arthur Pratt
et al.
Lack of association between clinical and ultrasound measures of disease activity in rheumatoid arthritis remission2020
Alex Clark
Dr Amy Anderson
Dr Nishanthi Thalayasingam
Najib Naamane
Julie Diboll
et al.
Lymphocyte DNA methylation mediates genetic risk at shared immune-mediated disease loci2020
Dr Dennis Lendrem
Dr Clare Lendrem
Dr Arthur Pratt
Professor John Isaacs
Professor David Jones
et al.
Schrödinger's pipeline and the outsourcing of pharmaceutical innovation2020
Dr Lilian Nwosu
Dr Arthur Pratt
Professor John Isaacs
Single-cell sequencing reveals clonal expansions of pro-inflammatory synovial CD8 T cells expressing tissue-homing receptors in psoriatic arthritis2020
Dr Stefan Siebert
Dr Arthur Pratt
Dr Deborah Stocken
Dr Miranda Morton
Amy Cranston
et al.
Targeting the rheumatoid arthritis synovial fibroblast via cyclin dependent kinase inhibition: An early phase trial2020
12345678